Identification

Name
Benzyl alcohol
Accession Number
DB06770
Type
Small Molecule
Groups
Approved
Description
Not Available
Structure
Thumb
Synonyms
  • (Hydroxymethyl)benzene
  • Alcoholum benzylicum
  • Alcool benzylique
  • Alcoolbenzylique
  • alpha-Hydroxytoluene
  • alpha-Toluenol
  • Aromatic alcohol
  • Bentalol
  • Benzalalcohol
  • Benzalcohol
  • Benzenecarbinol
  • Benzenemethanol
  • Benzoyl alcohol
  • Benzyl alcohol
  • Benzylalkohol
  • Benzylic alcohol
  • Hydroxymethylbenzene
  • Phenylcarbinol
  • Phenylmethanol
  • Phenylmethyl alcohol
External IDs
E-1519 / FEMA NO. 2137 / INS NO.1519 / INS-1519 / NSC-8044
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
UlesfiaLotion50 mg/gTopicalZylera Pharmaceuticals, LLC2014-07-16Not applicableUs
UlesfiaLotion50 mg/gTopicalShionogi2009-05-262016-10-13Us
UlesfiaLotion50 mg/gTopicalConcordia Pharmaceuticals, Inc2009-05-262016-10-13Us
UlesfiaLotion50 mg/gTopicalLachlan Pharmaceuticals2015-08-17Not applicableUs
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
AverteaxCream10 mg/gTopicalCamellix, LLC2014-01-01Not applicableUs
Baby's Own Teething Gel - 2.5%Gel2.5 %TopicalBlock Drug Company (Canada) Ltd.1998-03-022001-03-14Canada
Baby's Own Teething Gel 2.5%Gel2.5 %TopicalDannorth Laboratories Inc.1990-12-311997-08-12Canada
Babys Own Gora Teething LotLotion25 mgDentalG.T. Fulford Pharmaceuticals1961-12-311998-06-25Canada
Babys Own Teething GelGel25 mgDentalG.T. Fulford Pharmaceuticals1977-12-311998-06-25Canada
ProtocoxilGel100 mg/gTopicalBio ekuiliber llc2017-05-09Not applicableUs
ProtocoxilGel100 mg/gTopicalBio ekuiliber llc2017-05-09Not applicableUs
Zilactin Early Relief Cold SoreGel.1 g/gTopicalBlairex Laboratories, Inc.2005-06-30Not applicableUs
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
biochemistry PAIN RELIEF FOOT ACTIVEBenzyl alcohol (190 mg/mL) + Lidocaine hydrochloride (40 mg/mL)LiquidTopicalPure Source, Llc2014-02-06Not applicableUs
CiproBenzyl alcohol (9 mg/1mL) + Ciprofloxacin hydrochloride (2 mg/1mL) + Hydrocortisone (10 mg/1mL)SuspensionAuricular (otic)Physicians Total Care, Inc.2009-02-12Not applicableUs
Cipro HCBenzyl alcohol (9 mg/mL) + Ciprofloxacin (2 mg/mL) + Hydrocortisone (10 mg/mL)SuspensionAuricular (otic)Stat Rx USA1998-02-102018-02-08Us
Denture Orajel GelBenzyl alcohol (1 %) + Benzocaine (7.5 %) + Clove oil (0.2 %)GelBuccal; TopicalCommerce Pharmaceutics Inc.1997-12-172004-07-20Canada
Foille OntBenzyl alcohol (4 %) + Benzocaine (2 %)OintmentTopicalBlistex Corporation1980-12-312007-07-10Canada
Itch XBenzyl alcohol (10 g/100g) + Pramoxine hydrochloride (1 g/100g)GelTopicalBF ASCHER AND CO INC2014-09-19Not applicableUs
Itch X GelBenzyl alcohol (10 %) + Pramoxine hydrochloride (1 %)GelTopicalB.F. Ascher & Company Inc.1994-12-311998-07-09Canada
Itch-XBenzyl alcohol (10 g/100mL) + Pramoxine hydrochloride (1 g/100mL)SprayTopicalBF ASCHER AND CO INC2014-09-19Not applicableUs
Itch-X GelBenzyl alcohol (10 %) + Pramoxine hydrochloride (1 %)GelTopicalB.F. Ascher & Company Inc.1994-12-312002-07-09Canada
IvarestBenzyl alcohol (10.5 g/100g) + Diphenhydramine hydrochloride (2 g/100g) + Zinc oxide (14 g/100g)CreamTopicalBlistex Corporation2007-12-31Not applicableUs
Categories
UNII
LKG8494WBH
CAS number
100-51-6
Weight
Average: 108.1378
Monoisotopic: 108.057514878
Chemical Formula
C7H8O
InChI Key
WVDDGKGOMKODPV-UHFFFAOYSA-N
InChI
InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2
IUPAC Name
phenylmethanol
SMILES
OCC1=CC=CC=C1

Pharmacology

Indication

Ulesfia (benzyl alcohol) lotion is indicated for the topical treatment of head lice infestation in patients 6 months of age and older. Ulesfia Lotion does not have ovicidal activity.

Associated Conditions
Pharmacodynamics
Not Available
Mechanism of action

Benzyl alcohol inhibits lice from closing their respiratory spiracles, allowing the vehicle to obstruct the spiracles and causing the lice to asphyxiate.

Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity

1250 mg/kg (rat, oral) LD50 400 mg/kg IPR-RAT LD50 2000 mg/kg SKN-RBT LD50 53 mg/kg IVN-RAT LD50 2500 mg/kg ORL-GPG LD50

Affected organisms
  • Head lice
Pathways
PathwayCategory
glycerol metabolism IV (glycerophosphoglycerol)Metabolic
glycerol metabolism III (sn-glycero-3-phosphoethanolamine)Metabolic
glycerol metabolism V (glycerophosphoserine)Metabolic
hexuronide and hexuronate degradationMetabolic
glycerol metabolism IIMetabolic
glycerol metabolism V (glycerophosphoserine)Metabolic
hexuronide and hexuronate degradationMetabolic
glycerol metabolism IIMetabolic
glycerol metabolism III (sn-glycero-3-phosphoethanolamine)Metabolic
glycerol metabolism IV (glycerophosphoglycerol)Metabolic
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
2,5-Dimethoxy-4-ethylthioamphetamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.Experimental
3,4-MethylenedioxyamphetamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with 3,4-Methylenedioxyamphetamine.Experimental, Illicit
4-Bromo-2,5-dimethoxyamphetamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with 4-Bromo-2,5-dimethoxyamphetamine.Experimental, Illicit
4-MethoxyamphetamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with 4-Methoxyamphetamine.Experimental, Illicit
5-methoxy-N,N-dimethyltryptamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with 5-methoxy-N,N-dimethyltryptamine.Experimental, Illicit
7-NitroindazoleThe risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Benzyl alcohol.Experimental
7,8-Dichloro-1,2,3,4-tetrahydroisoquinolineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.Experimental
AbemaciclibThe serum concentration of Abemaciclib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
AcebutololThe serum concentration of Acebutolol can be increased when it is combined with Benzyl alcohol.Approved, Investigational
AcepromazineThe risk or severity of adverse effects can be increased when Acepromazine is combined with Benzyl alcohol.Approved, Vet Approved
AceprometazineThe risk or severity of adverse effects can be increased when Aceprometazine is combined with Benzyl alcohol.Approved
AcetazolamideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Acetazolamide.Approved, Vet Approved
AcetophenazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Acetophenazine.Approved
Acetylglycinamide chloral hydrateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Acetylglycinamide chloral hydrate.Experimental
Acetylsalicylic acidThe serum concentration of Acetylsalicylic acid can be increased when it is combined with Benzyl alcohol.Approved, Vet Approved
AdinazolamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Adinazolam.Approved
AdipiplonThe risk or severity of adverse effects can be increased when Adipiplon is combined with Benzyl alcohol.Investigational
AfatinibThe serum concentration of Afatinib can be increased when it is combined with Benzyl alcohol.Approved
AgomelatineThe risk or severity of adverse effects can be increased when Agomelatine is combined with Benzyl alcohol.Approved, Investigational
AlaproclateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Alaproclate.Experimental
AlcuroniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Alcuronium.Experimental
AldosteroneThe serum concentration of Aldosterone can be increased when it is combined with Benzyl alcohol.Experimental, Investigational
AlfaxaloneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Alfaxalone.Vet Approved
AlfentanilThe risk or severity of adverse effects can be increased when Alfentanil is combined with Benzyl alcohol.Approved, Illicit
AlimemazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Alimemazine.Approved, Vet Approved
AlitretinoinThe serum concentration of Alitretinoin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
AllobarbitalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Allobarbital.Experimental
AllopregnanoloneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Allopregnanolone.Investigational
AlmotriptanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Almotriptan.Approved, Investigational
AlosetronThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Alosetron.Approved, Withdrawn
AlphacetylmethadolThe risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Benzyl alcohol.Experimental, Illicit
AlphaprodineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Alphaprodine.Illicit
AlprazolamThe risk or severity of adverse effects can be increased when Alprazolam is combined with Benzyl alcohol.Approved, Illicit, Investigational
AlprenololThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Alprenolol.Approved, Withdrawn
AlverineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Alverine.Approved, Investigational
AmbrisentanThe serum concentration of Ambrisentan can be increased when it is combined with Benzyl alcohol.Approved, Investigational
AmikacinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Amikacin.Approved, Investigational, Vet Approved
AmineptineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Amineptine.Illicit, Withdrawn
AmiodaroneThe metabolism of Benzyl alcohol can be decreased when combined with Amiodarone.Approved, Investigational
AmisulprideThe risk or severity of adverse effects can be increased when Amisulpride is combined with Benzyl alcohol.Approved, Investigational
AmitriptylineThe risk or severity of adverse effects can be increased when Amitriptyline is combined with Benzyl alcohol.Approved
AmitriptylinoxideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Amitriptylinoxide.Approved, Investigational
AmobarbitalThe risk or severity of adverse effects can be increased when Amobarbital is combined with Benzyl alcohol.Approved, Illicit
AmoxapineThe risk or severity of adverse effects can be increased when Amoxapine is combined with Benzyl alcohol.Approved
AmperozideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Amperozide.Experimental
AmphetamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Amphetamine.Approved, Illicit, Investigational
AmprenavirThe serum concentration of Amprenavir can be increased when it is combined with Benzyl alcohol.Approved, Investigational
AniracetamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Aniracetam.Experimental
ApalutamideThe serum concentration of Benzyl alcohol can be decreased when it is combined with Apalutamide.Approved, Investigational
APD791The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with APD791.Investigational
ApixabanThe serum concentration of Apixaban can be increased when it is combined with Benzyl alcohol.Approved
ApomorphineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Apomorphine.Approved, Investigational
ApramycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Apramycin.Experimental, Vet Approved
AprepitantThe serum concentration of Benzyl alcohol can be increased when it is combined with Aprepitant.Approved, Investigational
AprobarbitalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Aprobarbital.Approved, Illicit
ApronalideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Apronalide.Experimental
Arbaclofen PlacarbilThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Arbaclofen Placarbil.Investigational
ArbekacinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Arbekacin.Approved, Investigational
AripiprazoleThe risk or severity of adverse effects can be increased when Aripiprazole is combined with Benzyl alcohol.Approved, Investigational
Aripiprazole lauroxilThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Aripiprazole lauroxil.Approved, Investigational
Arsenic trioxideThe serum concentration of Arsenic trioxide can be increased when it is combined with Benzyl alcohol.Approved, Investigational
Ascorbic acidThe serum concentration of Ascorbic acid can be increased when it is combined with Benzyl alcohol.Approved, Nutraceutical
AsenapineThe risk or severity of adverse effects can be increased when Asenapine is combined with Benzyl alcohol.Approved
AsunaprevirThe serum concentration of Asunaprevir can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Withdrawn
AtazanavirThe metabolism of Benzyl alcohol can be decreased when combined with Atazanavir.Approved, Investigational
AtomoxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Atomoxetine.Approved
AtorvastatinThe serum concentration of Atorvastatin can be increased when it is combined with Benzyl alcohol.Approved
AtracuriumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Atracurium.Approved, Experimental, Investigational
Atracurium besylateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Atracurium besylate.Approved
AvatrombopagThe serum concentration of Avatrombopag can be increased when it is combined with Benzyl alcohol.Approved, Investigational
AxitinibThe serum concentration of Axitinib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
AzaperoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Azaperone.Investigational, Vet Approved
AZD-3043The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with AZD-3043.Investigational
AzelastineBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.Approved
BaclofenThe risk or severity of adverse effects can be increased when Baclofen is combined with Benzyl alcohol.Approved
BarbexacloneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Barbexaclone.Experimental
BarbitalThe risk or severity of adverse effects can be increased when Barbital is combined with Benzyl alcohol.Illicit
BaricitinibThe serum concentration of Baricitinib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
BeclamideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Beclamide.Experimental
BekanamycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bekanamycin.Experimental
BelinostatThe serum concentration of Belinostat can be increased when it is combined with Benzyl alcohol.Approved, Investigational
BenactyzineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Benactyzine.Withdrawn
BenmoxinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Benmoxin.Withdrawn
BenperidolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Benperidol.Approved, Investigational
BenzoctamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Benzoctamine.Approved
BenzphetamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Benzphetamine.Approved, Illicit
BetamethasoneThe serum concentration of Betamethasone can be increased when it is combined with Benzyl alcohol.Approved, Vet Approved
BifemelaneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bifemelane.Experimental
BifeprunoxThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bifeprunox.Investigational
BL-1020The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with BL-1020.Investigational
BlonanserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Blonanserin.Approved, Investigational
BoceprevirThe metabolism of Benzyl alcohol can be decreased when combined with Boceprevir.Approved, Withdrawn
BosentanThe serum concentration of Benzyl alcohol can be decreased when it is combined with Bosentan.Approved, Investigational
BosutinibThe serum concentration of Bosutinib can be increased when it is combined with Benzyl alcohol.Approved
Botulinum Toxin Type AThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Botulinum Toxin Type A.Approved, Investigational
Botulinum Toxin Type BThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Botulinum Toxin Type B.Approved, Investigational
Brentuximab vedotinThe serum concentration of Brentuximab vedotin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
BrexpiprazoleThe risk or severity of adverse effects can be increased when Brexpiprazole is combined with Benzyl alcohol.Approved, Investigational
BrimonidineBrimonidine may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved
BrivaracetamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Brivaracetam.Approved, Investigational
BrofaromineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Brofaromine.Experimental
BromazepamThe risk or severity of adverse effects can be increased when Bromazepam is combined with Benzyl alcohol.Approved, Illicit, Investigational
BromisovalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bromisoval.Experimental
BromocriptineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bromocriptine.Approved, Investigational
BromperidolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bromperidol.Approved, Investigational
BrompheniramineThe risk or severity of adverse effects can be increased when Brompheniramine is combined with Benzyl alcohol.Approved
BrotizolamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Brotizolam.Approved, Investigational, Withdrawn
BufotenineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bufotenine.Experimental, Illicit
BuprenorphineBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.Approved, Illicit, Investigational, Vet Approved
BupropionThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bupropion.Approved
BuspironeThe risk or severity of adverse effects can be increased when Buspirone is combined with Benzyl alcohol.Approved, Investigational
ButabarbitalThe risk or severity of adverse effects can be increased when Butabarbital is combined with Benzyl alcohol.Approved, Illicit
ButalbitalThe risk or severity of adverse effects can be increased when Butalbital is combined with Benzyl alcohol.Approved, Illicit
ButaperazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Butaperazine.Experimental
ButethalThe risk or severity of adverse effects can be increased when Butethal is combined with Benzyl alcohol.Approved, Illicit
ButorphanolThe risk or severity of adverse effects can be increased when Butorphanol is combined with Benzyl alcohol.Approved, Illicit, Vet Approved
ButriptylineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Butriptyline.Approved
CabazitaxelThe serum concentration of Cabazitaxel can be increased when it is combined with Benzyl alcohol.Approved
CabergolineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cabergoline.Approved
CamazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Camazepam.Approved, Illicit
CamptothecinThe serum concentration of Camptothecin can be increased when it is combined with Benzyl alcohol.Experimental
CanagliflozinThe serum concentration of Canagliflozin can be increased when it is combined with Benzyl alcohol.Approved
CannabidiolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cannabidiol.Approved, Investigational
CannabidivarinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cannabidivarin.Investigational
CapreomycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Capreomycin.Approved
CaptodiameThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Captodiame.Approved, Investigational
CarbamazepineThe metabolism of Benzyl alcohol can be increased when combined with Carbamazepine.Approved, Investigational
CarbinoxamineThe risk or severity of adverse effects can be increased when Carbinoxamine is combined with Benzyl alcohol.Approved
CarbromalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Carbromal.Experimental
CarfentanilThe risk or severity of adverse effects can be increased when Carfentanil is combined with Benzyl alcohol.Illicit, Investigational, Vet Approved
CarfilzomibThe serum concentration of Carfilzomib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
CariprazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cariprazine.Approved, Investigational
CarisbamateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Carisbamate.Investigational
CarisoprodolThe risk or severity of adverse effects can be increased when Carisoprodol is combined with Benzyl alcohol.Approved
CaroxazoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Caroxazone.Withdrawn
CathinoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cathinone.Illicit
CeliprololThe serum concentration of Celiprolol can be increased when it is combined with Benzyl alcohol.Approved, Investigational
CeritinibThe serum concentration of Benzyl alcohol can be increased when it is combined with Ceritinib.Approved
CerivastatinThe serum concentration of Cerivastatin can be increased when it is combined with Benzyl alcohol.Approved, Withdrawn
CerlapirdineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cerlapirdine.Investigational
Cerliponase alfaThe serum concentration of Cerliponase alfa can be increased when it is combined with Benzyl alcohol.Approved, Investigational
CetirizineThe risk or severity of adverse effects can be increased when Cetirizine is combined with Benzyl alcohol.Approved
Chloral hydrateThe risk or severity of adverse effects can be increased when Chloral hydrate is combined with Benzyl alcohol.Approved, Illicit, Investigational, Vet Approved
ChlorambucilThe serum concentration of Chlorambucil can be increased when it is combined with Benzyl alcohol.Approved
ChlordiazepoxideThe risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Benzyl alcohol.Approved, Illicit, Investigational
ChlormezanoneThe risk or severity of adverse effects can be increased when Chlormezanone is combined with Benzyl alcohol.Approved, Investigational, Withdrawn
ChloroquineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Chloroquine.Approved, Investigational, Vet Approved
ChlorphenamineThe risk or severity of adverse effects can be increased when Chlorphenamine is combined with Benzyl alcohol.Approved
ChlorphenesinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Chlorphenesin.Approved, Vet Approved, Withdrawn
ChlorproethazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Chlorproethazine.Experimental
ChlorpromazineThe risk or severity of adverse effects can be increased when Chlorpromazine is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
ChlorprothixeneThe risk or severity of adverse effects can be increased when Chlorprothixene is combined with Benzyl alcohol.Approved, Investigational, Withdrawn
ChlortetracyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Chlortetracycline.Approved, Investigational, Vet Approved
ChlorzoxazoneThe risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Benzyl alcohol.Approved
CilansetronThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cilansetron.Investigational
CimetidineThe serum concentration of Cimetidine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
CinitaprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cinitapride.Approved, Investigational
CinolazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cinolazepam.Approved
CiprofloxacinThe serum concentration of Ciprofloxacin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
CisaprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cisapride.Approved, Investigational, Withdrawn
CisatracuriumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cisatracurium.Approved
CisplatinThe serum concentration of Cisplatin can be increased when it is combined with Benzyl alcohol.Approved
CitalopramThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Citalopram.Approved
ClarithromycinThe metabolism of Benzyl alcohol can be decreased when combined with Clarithromycin.Approved
ClemastineThe risk or severity of adverse effects can be increased when Clemastine is combined with Benzyl alcohol.Approved, Investigational
ClidiniumThe risk or severity of adverse effects can be increased when Clidinium is combined with Benzyl alcohol.Approved
ClindamycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Clindamycin.Approved, Vet Approved
ClobazamThe risk or severity of adverse effects can be increased when Clobazam is combined with Benzyl alcohol.Approved, Illicit
clomethiazoleThe risk or severity of adverse effects can be increased when clomethiazole is combined with Benzyl alcohol.Investigational
ClomipramineThe risk or severity of adverse effects can be increased when Clomipramine is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
ClomocyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Clomocycline.Approved
ClonazepamThe risk or severity of adverse effects can be increased when Clonazepam is combined with Benzyl alcohol.Approved, Illicit
ClonidineThe risk or severity of adverse effects can be increased when Clonidine is combined with Benzyl alcohol.Approved
ClopenthixolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Clopenthixol.Experimental
ClopidogrelThe serum concentration of Clopidogrel can be increased when it is combined with Benzyl alcohol.Approved
ClorazepateThe risk or severity of adverse effects can be increased when Clorazepate is combined with Benzyl alcohol.Approved, Illicit
ClothiapineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Clothiapine.Experimental
ClotiazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Clotiazepam.Approved, Illicit
ClotrimazoleThe metabolism of Benzyl alcohol can be decreased when combined with Clotrimazole.Approved, Vet Approved
CloxazolamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cloxazolam.Approved, Investigational
ClozapineThe risk or severity of adverse effects can be increased when Clozapine is combined with Benzyl alcohol.Approved
CobicistatThe metabolism of Benzyl alcohol can be decreased when combined with Cobicistat.Approved
CobimetinibThe serum concentration of Cobimetinib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
CodeineThe risk or severity of adverse effects can be increased when Codeine is combined with Benzyl alcohol.Approved, Illicit
ColchicineThe serum concentration of Colchicine can be increased when it is combined with Benzyl alcohol.Approved
ColistimethateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Colistimethate.Approved, Vet Approved
ColistinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Colistin.Approved
ConivaptanThe serum concentration of Conivaptan can be increased when it is combined with Benzyl alcohol.Approved, Investigational
Conjugated estrogensThe serum concentration of Conjugated estrogens can be increased when it is combined with Benzyl alcohol.Approved
CopanlisibThe serum concentration of Copanlisib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
CrizotinibThe serum concentration of Crizotinib can be increased when it is combined with Benzyl alcohol.Approved
CurcuminThe metabolism of Benzyl alcohol can be decreased when combined with Curcumin.Approved, Investigational
CyamemazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cyamemazine.Approved
CyclizineThe risk or severity of adverse effects can be increased when Cyclizine is combined with Benzyl alcohol.Approved
CyclobarbitalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cyclobarbital.Experimental
CyclobenzaprineThe risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Benzyl alcohol.Approved
CyclopropaneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cyclopropane.Experimental
CyclosporineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Cyclosporine.Approved, Investigational, Vet Approved
CyproheptadineThe risk or severity of adverse effects can be increased when Cyproheptadine is combined with Benzyl alcohol.Approved
Cyproterone acetateThe serum concentration of Benzyl alcohol can be decreased when it is combined with Cyproterone acetate.Approved, Investigational
CytarabineThe serum concentration of Cytarabine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
Dabigatran etexilateThe serum concentration of Dabigatran etexilate can be increased when it is combined with Benzyl alcohol.Approved
DabrafenibThe serum concentration of Benzyl alcohol can be decreased when it is combined with Dabrafenib.Approved, Investigational
DactinomycinThe serum concentration of Dactinomycin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
DanazolThe metabolism of Benzyl alcohol can be decreased when combined with Danazol.Approved
DantroleneThe risk or severity of adverse effects can be increased when Dantrolene is combined with Benzyl alcohol.Approved, Investigational
DapagliflozinThe serum concentration of Dapagliflozin can be increased when it is combined with Benzyl alcohol.Approved
DapiprazoleThe risk or severity of adverse effects can be increased when Dapiprazole is combined with Benzyl alcohol.Approved
DapoxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dapoxetine.Investigational
DarunavirThe metabolism of Benzyl alcohol can be decreased when combined with Darunavir.Approved
DasabuvirThe serum concentration of Dasabuvir can be increased when it is combined with Benzyl alcohol.Approved
DaunorubicinThe serum concentration of Daunorubicin can be increased when it is combined with Benzyl alcohol.Approved
DeanolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Deanol.Experimental
DebrisoquinThe serum concentration of Debrisoquin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
DecamethoniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Decamethonium.Approved
DeferasiroxThe serum concentration of Benzyl alcohol can be decreased when it is combined with Deferasirox.Approved, Investigational
DelavirdineThe metabolism of Benzyl alcohol can be decreased when combined with Delavirdine.Approved
DelorazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Delorazepam.Approved, Illicit, Investigational
DemeclocyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Demeclocycline.Approved
DeramciclaneThe risk or severity of adverse effects can be increased when Deramciclane is combined with Benzyl alcohol.Investigational
DesfluraneThe risk or severity of adverse effects can be increased when Desflurane is combined with Benzyl alcohol.Approved
DesipramineThe risk or severity of adverse effects can be increased when Desipramine is combined with Benzyl alcohol.Approved, Investigational
DesloratadineThe risk or severity of adverse effects can be increased when Desloratadine is combined with Benzyl alcohol.Approved, Investigational
DesvenlafaxineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Desvenlafaxine.Approved, Investigational
DetomidineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Detomidine.Vet Approved
DexamethasoneThe serum concentration of Dexamethasone can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
DexbrompheniramineThe risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Benzyl alcohol.Approved
DexmedetomidineThe risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Benzyl alcohol.Approved, Vet Approved
DexmethylphenidateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dexmethylphenidate.Approved, Investigational
DextofisopamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dextofisopam.Investigational
DextromethorphanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dextromethorphan.Approved
DextromoramideThe risk or severity of adverse effects can be increased when Dextromoramide is combined with Benzyl alcohol.Experimental, Illicit
DextropropoxypheneThe risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Benzyl alcohol.Approved, Illicit, Investigational, Withdrawn
DezocineThe risk or severity of adverse effects can be increased when Dezocine is combined with Benzyl alcohol.Approved, Investigational
DiazepamThe risk or severity of adverse effects can be increased when Diazepam is combined with Benzyl alcohol.Approved, Illicit, Investigational, Vet Approved
DibekacinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dibekacin.Experimental
DibenzepinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dibenzepin.Experimental
DichloralphenazoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dichloralphenazone.Approved, Illicit
Diethyl etherThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Diethyl ether.Experimental
DiethylstilbestrolThe serum concentration of Diethylstilbestrol can be increased when it is combined with Benzyl alcohol.Approved, Investigational
DifenoxinThe risk or severity of adverse effects can be increased when Difenoxin is combined with Benzyl alcohol.Approved, Illicit
DigitoxinThe serum concentration of Digitoxin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
DigoxinThe serum concentration of Digoxin can be increased when it is combined with Benzyl alcohol.Approved
DihydrocodeineThe risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Benzyl alcohol.Approved, Illicit
DihydroergotamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dihydroergotamine.Approved, Investigational
DihydroetorphineThe risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Benzyl alcohol.Experimental, Illicit
DihydromorphineThe risk or severity of adverse effects can be increased when Dihydromorphine is combined with Benzyl alcohol.Experimental, Illicit
DihydrostreptomycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dihydrostreptomycin.Investigational, Vet Approved
DiltiazemThe metabolism of Benzyl alcohol can be decreased when combined with Diltiazem.Approved, Investigational
DimenhydrinateThe risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Benzyl alcohol.Approved
DimetacrineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dimetacrine.Approved, Withdrawn
DimethyltryptamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dimethyltryptamine.Experimental, Illicit
DiphenhydramineThe risk or severity of adverse effects can be increased when Diphenhydramine is combined with Benzyl alcohol.Approved, Investigational
DiphenoxylateThe risk or severity of adverse effects can be increased when Diphenoxylate is combined with Benzyl alcohol.Approved, Illicit
DisulfiramThe metabolism of Benzyl alcohol can be decreased when combined with Disulfiram.Approved
DixyrazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dixyrazine.Experimental
DocetaxelThe serum concentration of Docetaxel can be increased when it is combined with Benzyl alcohol.Approved, Investigational
DolasetronThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dolasetron.Approved, Investigational
DolutegravirThe serum concentration of Dolutegravir can be increased when it is combined with Benzyl alcohol.Approved
Domoic AcidThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Domoic Acid.Experimental
DomperidoneThe serum concentration of Domperidone can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
DonepezilThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Donepezil.Approved
DoramectinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Doramectin.Vet Approved
DosulepinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dosulepin.Approved
DotarizineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Dotarizine.Investigational
DoxacuriumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Doxacurium.Approved
DoxefazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Doxefazepam.Experimental
DoxepinThe risk or severity of adverse effects can be increased when Doxepin is combined with Benzyl alcohol.Approved, Investigational
DoxorubicinThe serum concentration of Doxorubicin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
DoxycyclineThe metabolism of Benzyl alcohol can be decreased when combined with Doxycycline.Approved, Investigational, Vet Approved
DoxylamineDoxylamine may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved, Vet Approved
DPDPEThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with DPDPE.Experimental
DronabinolDronabinol may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved, Illicit
DronedaroneThe metabolism of Benzyl alcohol can be decreased when combined with Dronedarone.Approved
DroperidolDroperidol may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved, Vet Approved
DrotebanolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Benzyl alcohol.Experimental, Illicit
DuloxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Duloxetine.Approved
DyclonineThe risk or severity of adverse effects can be increased when Dyclonine is combined with Benzyl alcohol.Approved
EcopipamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ecopipam.Investigational
EdivoxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Edivoxetine.Investigational
EdoxabanThe serum concentration of Edoxaban can be increased when it is combined with Benzyl alcohol.Approved
EfavirenzThe metabolism of Benzyl alcohol can be decreased when combined with Efavirenz.Approved, Investigational
ElagolixThe serum concentration of Elagolix can be increased when it is combined with Benzyl alcohol.Approved, Investigational
ElbasvirThe serum concentration of Elbasvir can be increased when it is combined with Benzyl alcohol.Approved
EletriptanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Eletriptan.Approved, Investigational
EltanoloneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Eltanolone.Investigational
EltoprazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Eltoprazine.Investigational
EmeproniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Emepronium.Experimental
EmylcamateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Emylcamate.Experimental
EnfluraneThe risk or severity of adverse effects can be increased when Enflurane is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
EntacaponeThe risk or severity of adverse effects can be increased when Entacapone is combined with Benzyl alcohol.Approved, Investigational
EnzalutamideThe serum concentration of Benzyl alcohol can be decreased when it is combined with Enzalutamide.Approved
EperisoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Eperisone.Approved, Investigational
EpinastineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Epinastine.Approved, Investigational
EplivanserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Eplivanserin.Investigational
Ergoloid mesylateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ergoloid mesylate.Approved
ErgonovineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ergonovine.Approved
ErgotamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ergotamine.Approved
ErlotinibThe serum concentration of Erlotinib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
ErtugliflozinThe serum concentration of Ertugliflozin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
ErythromycinThe serum concentration of Erythromycin can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
EscitalopramThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Escitalopram.Approved, Investigational
Eslicarbazepine acetateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Eslicarbazepine acetate.Approved
EsmirtazapineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Esmirtazapine.Investigational
EsreboxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Esreboxetine.Investigational
EstazolamThe risk or severity of adverse effects can be increased when Estazolam is combined with Benzyl alcohol.Approved, Illicit
EstradiolThe serum concentration of Estradiol can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
Estradiol acetateThe serum concentration of Estradiol acetate can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
Estradiol benzoateThe serum concentration of Estradiol benzoate can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
Estradiol cypionateThe serum concentration of Estradiol cypionate can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
Estradiol dienanthateThe serum concentration of Estradiol dienanthate can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
Estradiol valerateThe serum concentration of Estradiol valerate can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
EstriolThe serum concentration of Estriol can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
EstroneThe serum concentration of Estrone can be increased when it is combined with Benzyl alcohol.Approved
EszopicloneThe risk or severity of adverse effects can be increased when Eszopiclone is combined with Benzyl alcohol.Approved, Investigational
Etacrynic acidThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Etacrynic acid.Approved, Investigational
EthadioneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ethadione.Experimental
EthanolBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.Approved
EthchlorvynolThe risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Benzyl alcohol.Approved, Illicit, Withdrawn
Ethinyl EstradiolThe serum concentration of Ethinyl Estradiol can be increased when it is combined with Benzyl alcohol.Approved
EthosuximideThe risk or severity of adverse effects can be increased when Ethosuximide is combined with Benzyl alcohol.Approved
EthotoinThe risk or severity of adverse effects can be increased when Ethotoin is combined with Benzyl alcohol.Approved
Ethyl carbamateThe risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Benzyl alcohol.Withdrawn
Ethyl chlorideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ethyl chloride.Approved, Experimental, Investigational
Ethyl loflazepateThe risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Benzyl alcohol.Approved, Illicit
EthylmorphineThe risk or severity of adverse effects can be increased when Ethylmorphine is combined with Benzyl alcohol.Approved, Illicit
EtifoxineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Etifoxine.Investigational, Withdrawn
EtiracetamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Etiracetam.Investigational
EtizolamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Etizolam.Approved
EtomidateThe risk or severity of adverse effects can be increased when Etomidate is combined with Benzyl alcohol.Approved
EtoperidoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Etoperidone.Withdrawn
EtoposideThe serum concentration of Etoposide can be increased when it is combined with Benzyl alcohol.Approved
EtorphineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Etorphine.Illicit, Vet Approved
EtravirineThe serum concentration of Benzyl alcohol can be decreased when it is combined with Etravirine.Approved
EverolimusThe serum concentration of Everolimus can be increased when it is combined with Benzyl alcohol.Approved
EzetimibeThe serum concentration of Ezetimibe can be increased when it is combined with Benzyl alcohol.Approved
EzogabineThe risk or severity of adverse effects can be increased when Ezogabine is combined with Benzyl alcohol.Approved, Investigational
FabomotizoleThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Fabomotizole.Experimental
Fazadinium bromideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Fazadinium bromide.Experimental
FebarbamateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Febarbamate.Experimental
FelbamateThe risk or severity of adverse effects can be increased when Felbamate is combined with Benzyl alcohol.Approved
FencamfamineThe risk or severity of adverse effects can be increased when Fencamfamine is combined with Benzyl alcohol.Approved, Illicit, Withdrawn
FenfluramineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Fenfluramine.Approved, Illicit, Investigational, Withdrawn
FentanylThe risk or severity of adverse effects can be increased when Fentanyl is combined with Benzyl alcohol.Approved, Illicit, Investigational, Vet Approved
FenyramidolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Fenyramidol.Experimental
FesoterodineThe serum concentration of Fesoterodine can be increased when it is combined with Benzyl alcohol.Approved
FexofenadineThe risk or severity of adverse effects can be increased when Fexofenadine is combined with Benzyl alcohol.Approved, Investigational
FidaxomicinThe serum concentration of Fidaxomicin can be increased when it is combined with Benzyl alcohol.Approved
FlibanserinThe risk or severity of adverse effects can be increased when Flibanserin is combined with Benzyl alcohol.Approved, Investigational
FluanisoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Fluanisone.Experimental
Fluciclovine (18F)The serum concentration of Fluciclovine (18F) can be increased when it is combined with Benzyl alcohol.Approved
FluconazoleThe metabolism of Benzyl alcohol can be decreased when combined with Fluconazole.Approved, Investigational
FludiazepamThe risk or severity of adverse effects can be increased when Fludiazepam is combined with Benzyl alcohol.Approved, Illicit
FlunarizineThe risk or severity of adverse effects can be increased when Flunarizine is combined with Benzyl alcohol.Approved
FlunitrazepamThe risk or severity of adverse effects can be increased when Flunitrazepam is combined with Benzyl alcohol.Approved, Illicit
FluoxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Fluoxetine.Approved, Vet Approved
FlupentixolThe risk or severity of adverse effects can be increased when Flupentixol is combined with Benzyl alcohol.Approved, Investigational, Withdrawn
FluphenazineThe risk or severity of adverse effects can be increased when Fluphenazine is combined with Benzyl alcohol.Approved
FlurazepamThe risk or severity of adverse effects can be increased when Flurazepam is combined with Benzyl alcohol.Approved, Illicit, Investigational
FluspirileneThe risk or severity of adverse effects can be increased when Fluspirilene is combined with Benzyl alcohol.Approved, Investigational
FluticasoneThe serum concentration of Fluticasone can be increased when it is combined with Benzyl alcohol.Approved, Experimental, Investigational
Fluticasone furoateThe serum concentration of Fluticasone furoate can be increased when it is combined with Benzyl alcohol.Approved
Fluticasone propionateThe risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Benzyl alcohol.Approved
FluvoxamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Fluvoxamine.Approved, Investigational
FosamprenavirThe metabolism of Benzyl alcohol can be decreased when combined with Fosamprenavir.Approved
FosaprepitantThe serum concentration of Benzyl alcohol can be increased when it is combined with Fosaprepitant.Approved
FosphenytoinThe metabolism of Benzyl alcohol can be increased when combined with Fosphenytoin.Approved, Investigational
FospropofolThe risk or severity of adverse effects can be increased when Fospropofol is combined with Benzyl alcohol.Approved, Illicit, Investigational
FramycetinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Framycetin.Approved
FrovatriptanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Frovatriptan.Approved, Investigational
FurazolidoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Furazolidone.Approved, Investigational, Vet Approved
Fusidic AcidThe serum concentration of Benzyl alcohol can be increased when it is combined with Fusidic Acid.Approved, Investigational
GabapentinThe risk or severity of adverse effects can be increased when Gabapentin is combined with Benzyl alcohol.Approved, Investigational
Gabapentin EnacarbilThe risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Benzyl alcohol.Approved, Investigational
GaboxadolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Gaboxadol.Investigational
GallamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Gallamine.Experimental
Gallamine TriethiodideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Gallamine Triethiodide.Approved
Gamma Hydroxybutyric AcidThe risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Benzyl alcohol.Approved, Illicit, Investigational
Gantacurium ChlorideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Gantacurium Chloride.Investigational
GedocarnilThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Gedocarnil.Experimental
GefitinibThe serum concentration of Gefitinib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
GeneticinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Geneticin.Experimental
GentamicinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Gentamicin.Approved, Vet Approved
GENTAMICIN C1AThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with GENTAMICIN C1A.Experimental
GepironeThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Gepirone.Investigational
GlecaprevirThe serum concentration of Glecaprevir can be increased when it is combined with Benzyl alcohol.Approved, Investigational
GlutethimideThe risk or severity of adverse effects can be increased when Glutethimide is combined with Benzyl alcohol.Approved, Illicit
Gramicidin DThe serum concentration of Gramicidin D can be increased when it is combined with Benzyl alcohol.Approved
GranisetronThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Granisetron.Approved, Investigational
GrazoprevirThe serum concentration of Grazoprevir can be increased when it is combined with Benzyl alcohol.Approved
GrepafloxacinThe serum concentration of Grepafloxacin can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Withdrawn
GuanfacineThe risk or severity of adverse effects can be increased when Guanfacine is combined with Benzyl alcohol.Approved, Investigational
HalazepamThe risk or severity of adverse effects can be increased when Halazepam is combined with Benzyl alcohol.Approved, Illicit, Withdrawn
HaloperidolThe risk or severity of adverse effects can be increased when Haloperidol is combined with Benzyl alcohol.Approved
HalothaneThe risk or severity of adverse effects can be increased when Halothane is combined with Benzyl alcohol.Approved, Vet Approved
HarmalineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Harmaline.Experimental
HeptabarbitalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Heptabarbital.Approved
HeroinThe risk or severity of adverse effects can be increased when Heroin is combined with Benzyl alcohol.Approved, Illicit, Investigational
HexafluroniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Hexafluronium.Approved
HexamethoniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Hexamethonium.Experimental
HexapropymateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Hexapropymate.Experimental
HexobarbitalThe risk or severity of adverse effects can be increased when Hexobarbital is combined with Benzyl alcohol.Approved
HyaluronidaseHyaluronidase can cause an increase in the absorption of Benzyl alcohol resulting in an increased serum concentration and potentially a worsening of adverse effects.Approved, Investigational
HydracarbazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Hydracarbazine.Experimental
HydrocodoneBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.Approved, Illicit
HydrocortisoneThe serum concentration of Hydrocortisone can be increased when it is combined with Benzyl alcohol.Approved, Vet Approved
HydromorphoneThe risk or severity of adverse effects can be increased when Hydromorphone is combined with Benzyl alcohol.Approved, Illicit
HydroxyureaThe serum concentration of Hydroxyurea can be increased when it is combined with Benzyl alcohol.Approved
HydroxyzineHydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved
Hygromycin BThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Hygromycin B.Vet Approved
HypericinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Hypericin.Investigational
IdalopirdineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Idalopirdine.Investigational
IdelalisibThe metabolism of Benzyl alcohol can be decreased when combined with Idelalisib.Approved
IfenprodilThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ifenprodil.Approved, Investigational, Withdrawn
IferanserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Iferanserin.Investigational
IloperidoneThe risk or severity of adverse effects can be increased when Iloperidone is combined with Benzyl alcohol.Approved
ImagabalinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Imagabalin.Investigational
ImatinibThe serum concentration of Imatinib can be increased when it is combined with Benzyl alcohol.Approved
ImipramineThe risk or severity of adverse effects can be increased when Imipramine is combined with Benzyl alcohol.Approved
Imipramine oxideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Imipramine oxide.Experimental
IndacaterolThe serum concentration of Indacaterol can be increased when it is combined with Benzyl alcohol.Approved
IndalpineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Indalpine.Investigational, Withdrawn
IndinavirThe metabolism of Benzyl alcohol can be decreased when combined with Indinavir.Approved
IndiplonThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Indiplon.Investigational
Inotuzumab ozogamicinThe serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
IprazochromeThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Iprazochrome.Experimental
IprindoleThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Iprindole.Experimental
IproclozideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Iproclozide.Withdrawn
IproniazidThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Iproniazid.Withdrawn
IrinotecanThe serum concentration of Irinotecan can be increased when it is combined with Benzyl alcohol.Approved, Investigational
IsavuconazoleThe serum concentration of Benzyl alcohol can be increased when it is combined with Isavuconazole.Approved, Investigational
IsavuconazoniumThe metabolism of Benzyl alcohol can be decreased when combined with Isavuconazonium.Approved, Investigational
IsepamicinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Isepamicin.Experimental
IsocarboxazidThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Isocarboxazid.Approved
IsofluraneThe risk or severity of adverse effects can be increased when Isoflurane is combined with Benzyl alcohol.Approved, Vet Approved
IsoniazidThe metabolism of Benzyl alcohol can be decreased when combined with Isoniazid.Approved, Investigational
ItraconazoleThe metabolism of Benzyl alcohol can be decreased when combined with Itraconazole.Approved, Investigational
IvacaftorThe serum concentration of Benzyl alcohol can be increased when it is combined with Ivacaftor.Approved
IvermectinThe serum concentration of Ivermectin can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
IvosidenibThe serum concentration of Ivosidenib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
KanamycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Kanamycin.Approved, Investigational, Vet Approved
KetamineThe risk or severity of adverse effects can be increased when Ketamine is combined with Benzyl alcohol.Approved, Vet Approved
KetanserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ketanserin.Investigational
KetazolamThe risk or severity of adverse effects can be increased when Ketazolam is combined with Benzyl alcohol.Approved
KetobemidoneThe risk or severity of adverse effects can be increased when Ketobemidone is combined with Benzyl alcohol.Approved, Investigational
KetoconazoleThe metabolism of Benzyl alcohol can be decreased when combined with Ketoconazole.Approved, Investigational
L-TryptophanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with L-Tryptophan.Approved, Nutraceutical, Withdrawn
LacosamideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lacosamide.Approved
LamivudineThe serum concentration of Lamivudine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
LamotrigineThe risk or severity of adverse effects can be increased when Lamotrigine is combined with Benzyl alcohol.Approved, Investigational
LanicemineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lanicemine.Investigational
LansoprazoleThe serum concentration of Lansoprazole can be increased when it is combined with Benzyl alcohol.Approved, Investigational
LasmiditanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lasmiditan.Investigational
LedipasvirThe serum concentration of Ledipasvir can be increased when it is combined with Benzyl alcohol.Approved
LenalidomideThe serum concentration of Lenalidomide can be increased when it is combined with Benzyl alcohol.Approved
LenvatinibThe serum concentration of Lenvatinib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
LetermovirThe serum concentration of Letermovir can be increased when it is combined with Benzyl alcohol.Approved, Investigational
LevetiracetamThe risk or severity of adverse effects can be increased when Levetiracetam is combined with Benzyl alcohol.Approved, Investigational
LevocabastineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Levocabastine.Approved, Investigational
LevocetirizineThe risk or severity of adverse effects can be increased when Levocetirizine is combined with Benzyl alcohol.Approved
LevodopaThe risk or severity of adverse effects can be increased when Levodopa is combined with Benzyl alcohol.Approved
LevofloxacinThe serum concentration of Levofloxacin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
Levomethadyl AcetateThe risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Benzyl alcohol.Approved, Investigational
LevomilnacipranThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Levomilnacipran.Approved, Investigational
LevorphanolThe risk or severity of adverse effects can be increased when Levorphanol is combined with Benzyl alcohol.Approved
LinagliptinThe serum concentration of Linagliptin can be increased when it is combined with Benzyl alcohol.Approved
LincomycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lincomycin.Approved, Vet Approved
LinezolidThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Linezolid.Approved, Investigational
LisurideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lisuride.Approved, Investigational
Lithium carbonateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lithium carbonate.Approved
Lithium cationThe risk or severity of adverse effects can be increased when Lithium cation is combined with Benzyl alcohol.Experimental
LofentanilThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lofentanil.Illicit
LofepramineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lofepramine.Experimental
LofexidineThe therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Lofexidine.Approved, Investigational
LoperamideThe serum concentration of Loperamide can be increased when it is combined with Benzyl alcohol.Approved
LopinavirThe metabolism of Benzyl alcohol can be decreased when combined with Lopinavir.Approved
LoprazolamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Loprazolam.Experimental
LoratadineThe risk or severity of adverse effects can be increased when Loratadine is combined with Benzyl alcohol.Approved, Investigational
LorazepamThe risk or severity of adverse effects can be increased when Lorazepam is combined with Benzyl alcohol.Approved
LorcaserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lorcaserin.Approved
LormetazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lormetazepam.Approved
LorpiprazoleThe serum concentration of Benzyl alcohol can be increased when it is combined with Lorpiprazole.Approved
LortalamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lortalamine.Experimental
LosartanThe serum concentration of Losartan can be increased when it is combined with Benzyl alcohol.Approved
LovastatinThe serum concentration of Lovastatin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
LoxapineThe risk or severity of adverse effects can be increased when Loxapine is combined with Benzyl alcohol.Approved
LuliconazoleThe serum concentration of Benzyl alcohol can be increased when it is combined with Luliconazole.Approved
LumacaftorThe metabolism of Benzyl alcohol can be increased when combined with Lumacaftor.Approved
LumateperoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lumateperone.Investigational
LurasidoneThe risk or severity of adverse effects can be increased when Lurasidone is combined with Benzyl alcohol.Approved, Investigational
LusutrombopagThe serum concentration of Lusutrombopag can be increased when it is combined with Benzyl alcohol.Approved, Investigational
LymecyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lymecycline.Approved, Investigational
Lysergic Acid DiethylamideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Lysergic Acid Diethylamide.Illicit, Investigational, Withdrawn
m-ChlorophenylpiperazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with m-Chlorophenylpiperazine.Investigational
Magnesium acetateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium acetate.Approved
Magnesium acetate tetrahydrateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium acetate tetrahydrate.Approved
Magnesium Aluminum SilicateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium Aluminum Silicate.Approved
Magnesium aspartateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium aspartate.Experimental
Magnesium carbonateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium carbonate.Approved, Investigational
Magnesium cationThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium cation.Approved, Nutraceutical
Magnesium chlorideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium chloride.Approved
Magnesium citrateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium citrate.Approved
Magnesium gluconateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium gluconate.Approved, Investigational
Magnesium glycinateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium glycinate.Approved
Magnesium hydroxideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium hydroxide.Approved, Investigational
Magnesium orotateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium orotate.Experimental
Magnesium oxideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium oxide.Approved
Magnesium phosphateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium phosphate.Experimental
Magnesium silicateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium silicate.Approved
Magnesium stearateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium stearate.Investigational
Magnesium sulfateThe therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Magnesium sulfate.Approved, Investigational, Vet Approved
Magnesium TrisilicateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium Trisilicate.Approved
MaprotilineThe risk or severity of adverse effects can be increased when Maprotiline is combined with Benzyl alcohol.Approved, Investigational
MazindolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mazindol.Approved, Investigational
MebanazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mebanazine.Withdrawn
MebicarThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mebicar.Experimental
MebutamateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mebutamate.Approved
MecamylamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mecamylamine.Approved, Investigational
MeclizineThe risk or severity of adverse effects can be increased when Meclizine is combined with Benzyl alcohol.Approved
MedazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Medazepam.Experimental
MedetomidineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Medetomidine.Vet Approved
MedifoxamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Medifoxamine.Experimental
MefloquineThe serum concentration of Mefloquine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
MelatoninThe risk or severity of adverse effects can be increased when Melatonin is combined with Benzyl alcohol.Approved, Nutraceutical, Vet Approved
MelitracenThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Melitracen.Experimental, Investigational
MelperoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Melperone.Approved, Investigational
MelphalanThe serum concentration of Melphalan can be increased when it is combined with Benzyl alcohol.Approved
MephenesinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mephenesin.Approved
MephenoxaloneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mephenoxalone.Experimental
MephenytoinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mephenytoin.Investigational, Withdrawn
MeprobamateThe risk or severity of adverse effects can be increased when Meprobamate is combined with Benzyl alcohol.Approved, Illicit
MeptazinolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Meptazinol.Experimental
MesoridazineThe risk or severity of adverse effects can be increased when Mesoridazine is combined with Benzyl alcohol.Approved, Investigational
MetaxaloneThe risk or severity of adverse effects can be increased when Metaxalone is combined with Benzyl alcohol.Approved
MetergolineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Metergoline.Experimental
MethacyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Methacycline.Approved, Investigational
MethadoneThe risk or severity of adverse effects can be increased when Methadone is combined with Benzyl alcohol.Approved
Methadyl AcetateThe risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Benzyl alcohol.Approved, Illicit
MethamphetamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Methamphetamine.Approved, Illicit
MethapyrileneThe risk or severity of adverse effects can be increased when Methapyrilene is combined with Benzyl alcohol.Withdrawn
MethaqualoneThe risk or severity of adverse effects can be increased when Methaqualone is combined with Benzyl alcohol.Illicit, Withdrawn
MetharbitalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Metharbital.Withdrawn
MethocarbamolThe risk or severity of adverse effects can be increased when Methocarbamol is combined with Benzyl alcohol.Approved, Vet Approved
MethohexitalThe risk or severity of adverse effects can be increased when Methohexital is combined with Benzyl alcohol.Approved
MethotrexateThe serum concentration of Methotrexate can be increased when it is combined with Benzyl alcohol.Approved
MethotrimeprazineBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.Approved, Investigational
MethoxyfluraneThe risk or severity of adverse effects can be increased when Methoxyflurane is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
MethsuximideThe risk or severity of adverse effects can be increased when Methsuximide is combined with Benzyl alcohol.Approved
Methylene blueThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Methylene blue.Approved, Investigational
MethylpentynolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Methylpentynol.Experimental
MethylphenidateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Methylphenidate.Approved, Investigational
MethylphenobarbitalThe risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Benzyl alcohol.Approved
MethylprednisoloneThe serum concentration of Methylprednisolone can be increased when it is combined with Benzyl alcohol.Approved, Vet Approved
MethyprylonThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Methyprylon.Approved, Illicit, Withdrawn
MethysergideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Methysergide.Approved
MetocurineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Metocurine.Approved
Metocurine IodideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Metocurine Iodide.Approved, Withdrawn
MetyrosineBenzyl alcohol may increase the sedative activities of Metyrosine.Approved
MianserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mianserin.Approved, Investigational
MibefradilThe metabolism of Benzyl alcohol can be decreased when combined with Mibefradil.Investigational, Withdrawn
MiconazoleThe metabolism of Benzyl alcohol can be decreased when combined with Miconazole.Approved, Investigational, Vet Approved
MicronomicinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Micronomicin.Experimental
MidazolamThe risk or severity of adverse effects can be increased when Midazolam is combined with Benzyl alcohol.Approved, Illicit
MidomafetamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Midomafetamine.Experimental, Illicit, Investigational
MidostaurinThe metabolism of Benzyl alcohol can be decreased when combined with Midostaurin.Approved, Investigational
MifepristoneThe serum concentration of Benzyl alcohol can be increased when it is combined with Mifepristone.Approved, Investigational
MilnacipranThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Milnacipran.Approved, Investigational
MinaprineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Minaprine.Approved
MinocyclineMinocycline may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved, Investigational
MirabegronThe serum concentration of Mirabegron can be increased when it is combined with Benzyl alcohol.Approved
MirtazapineBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.Approved
MitomycinThe serum concentration of Mitomycin can be increased when it is combined with Benzyl alcohol.Approved
MitotaneThe serum concentration of Benzyl alcohol can be decreased when it is combined with Mitotane.Approved
MitoxantroneThe serum concentration of Mitoxantrone can be increased when it is combined with Benzyl alcohol.Approved, Investigational
MivacuriumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mivacurium.Approved
MK-212The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with MK-212.Investigational
MMDAThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with MMDA.Experimental, Illicit
MoclobemideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Moclobemide.Approved, Investigational
ModafinilThe serum concentration of Benzyl alcohol can be decreased when it is combined with Modafinil.Approved, Investigational
MolindoneThe risk or severity of adverse effects can be increased when Molindone is combined with Benzyl alcohol.Approved
MoperoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Moperone.Experimental
MoricizineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Moricizine.Approved, Investigational, Withdrawn
MorphineThe risk or severity of adverse effects can be increased when Morphine is combined with Benzyl alcohol.Approved, Investigational
MosapramineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mosapramine.Experimental
MosaprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Mosapride.Investigational
MoxidectinThe serum concentration of Moxidectin can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
MRK-409The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with MRK-409.Experimental
Mycophenolate mofetilThe serum concentration of Mycophenolate mofetil can be increased when it is combined with Benzyl alcohol.Approved, Investigational
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.Experimental
NabiloneNabilone may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved, Investigational
NadololThe serum concentration of Nadolol can be increased when it is combined with Benzyl alcohol.Approved
NafcillinThe serum concentration of Benzyl alcohol can be decreased when it is combined with Nafcillin.Approved, Investigational
NaftidrofurylThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Naftidrofuryl.Experimental
NalbuphineThe risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzyl alcohol.Approved
NaloxegolThe serum concentration of Naloxegol can be increased when it is combined with Benzyl alcohol.Approved
NaloxoneThe metabolism of Benzyl alcohol can be decreased when combined with Naloxone.Approved, Vet Approved
NaluzotanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Naluzotan.Investigational
NaratriptanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Naratriptan.Approved, Investigational
NaronaprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Naronapride.Investigational
NeamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Neamine.Experimental
NefazodoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Nefazodone.Approved, Withdrawn
NefiracetamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Nefiracetam.Investigational
NelfinavirThe metabolism of Benzyl alcohol can be decreased when combined with Nelfinavir.Approved
NeocitrullamonThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Neocitrullamon.Experimental
NeomycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Neomycin.Approved, Vet Approved
NeosaxitoxinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Neosaxitoxin.Investigational
NeostigmineThe serum concentration of Neostigmine can be increased when it is combined with Benzyl alcohol.Approved, Vet Approved
NetilmicinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Netilmicin.Approved, Investigational
NetupitantThe serum concentration of Benzyl alcohol can be increased when it is combined with Netupitant.Approved, Investigational
NevirapineThe metabolism of Benzyl alcohol can be increased when combined with Nevirapine.Approved
NialamideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Nialamide.Withdrawn
NiaprazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Niaprazine.Experimental
NicardipineThe serum concentration of Nicardipine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
NifedipineThe serum concentration of Nifedipine can be increased when it is combined with Benzyl alcohol.Approved
NilotinibThe metabolism of Benzyl alcohol can be decreased when combined with Nilotinib.Approved, Investigational
NintedanibThe serum concentration of Nintedanib can be increased when it is combined with Benzyl alcohol.Approved
NisoxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Nisoxetine.Experimental
NitrazepamThe risk or severity of adverse effects can be increased when Nitrazepam is combined with Benzyl alcohol.Approved
Nitrous oxideThe risk or severity of adverse effects can be increased when Nitrous oxide is combined with Benzyl alcohol.Approved, Vet Approved
NizatidineThe serum concentration of Nizatidine can be increased when it is combined with Benzyl alcohol.Approved
NomifensineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Nomifensine.Withdrawn
NordazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Nordazepam.Approved
NormethadoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Normethadone.Approved, Illicit
NortriptylineThe risk or severity of adverse effects can be increased when Nortriptyline is combined with Benzyl alcohol.Approved
OctamoxinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Octamoxin.Withdrawn
OctreotideThe serum concentration of Octreotide can be increased when it is combined with Benzyl alcohol.Approved, Investigational
OdanacatibThe serum concentration of Odanacatib can be increased when it is combined with Benzyl alcohol.Investigational
OlanzapineThe risk or severity of adverse effects can be increased when Olanzapine is combined with Benzyl alcohol.Approved, Investigational
OlaparibThe metabolism of Benzyl alcohol can be decreased when combined with Olaparib.Approved
OlopatadineThe risk or severity of adverse effects can be increased when Olopatadine is combined with Benzyl alcohol.Approved
OmbitasvirThe serum concentration of Ombitasvir can be increased when it is combined with Benzyl alcohol.Approved, Investigational
OmeprazoleThe serum concentration of Omeprazole can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
OndansetronThe risk or severity of adverse effects can be increased when Ondansetron is combined with Benzyl alcohol.Approved
OpipramolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Opipramol.Investigational
OpiumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Opium.Approved, Illicit
OrphenadrineBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.Approved
OrvepitantThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Orvepitant.Investigational
OsanetantThe risk or severity of adverse effects can be increased when Osanetant is combined with Benzyl alcohol.Investigational
OxaflozaneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Oxaflozane.Experimental
OxaprotilineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Oxaprotiline.Experimental
OxazepamThe risk or severity of adverse effects can be increased when Oxazepam is combined with Benzyl alcohol.Approved
OxcarbazepineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Oxcarbazepine.Approved
OxiracetamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Oxiracetam.Experimental
OxitriptanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Oxitriptan.Approved, Investigational, Nutraceutical
OxprenololThe risk or severity of adverse effects can be increased when Oxprenolol is combined with Benzyl alcohol.Approved
OxycodoneThe risk or severity of adverse effects can be increased when Oxycodone is combined with Benzyl alcohol.Approved, Illicit, Investigational
OxymorphoneThe risk or severity of adverse effects can be increased when Oxymorphone is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
OxypertineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Oxypertine.Experimental
OxytetracyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Oxytetracycline.Approved, Investigational, Vet Approved
PaclitaxelThe serum concentration of Paclitaxel can be increased when it is combined with Benzyl alcohol.Approved, Vet Approved
PalbociclibThe serum concentration of Benzyl alcohol can be increased when it is combined with Palbociclib.Approved, Investigational
PaliperidoneThe risk or severity of adverse effects can be increased when Paliperidone is combined with Benzyl alcohol.Approved
PalonosetronThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Palonosetron.Approved, Investigational
PancuroniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pancuronium.Approved
PanobinostatThe serum concentration of Panobinostat can be increased when it is combined with Benzyl alcohol.Approved, Investigational
PantoprazoleThe serum concentration of Pantoprazole can be increased when it is combined with Benzyl alcohol.Approved
ParaldehydeBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.Approved, Investigational
ParamethadioneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Paramethadione.Approved
PargylineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pargyline.Approved
ParitaprevirThe serum concentration of Paritaprevir can be increased when it is combined with Benzyl alcohol.Approved, Investigational
ParomomycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Paromomycin.Approved, Investigational
ParoxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Paroxetine.Approved, Investigational
PazopanibThe serum concentration of Pazopanib can be increased when it is combined with Benzyl alcohol.Approved
PenbutololThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Penbutolol.Approved, Investigational
PenfluridolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Penfluridol.Experimental
PenimepicyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Penimepicycline.Experimental
PentazocineThe risk or severity of adverse effects can be increased when Pentazocine is combined with Benzyl alcohol.Approved, Vet Approved
PentobarbitalThe metabolism of Benzyl alcohol can be increased when combined with Pentobarbital.Approved, Investigational, Vet Approved
PerampanelPerampanel may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved
PerazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Perazine.Approved, Investigational
PergolideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pergolide.Approved, Investigational, Vet Approved, Withdrawn
PerospironeThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Perospirone.Approved
PerphenazineThe risk or severity of adverse effects can be increased when Perphenazine is combined with Benzyl alcohol.Approved
PethidineThe risk or severity of adverse effects can be increased when Pethidine is combined with Benzyl alcohol.Approved
PhenacemideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phenacemide.Approved
PhenazocineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phenazocine.Experimental
PhencyclidineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phencyclidine.Illicit
PhenelzineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phenelzine.Approved
PhenethylamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phenethylamine.Experimental
PheneturideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pheneturide.Experimental
PhenibutThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phenibut.Experimental
PheniprazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pheniprazine.Withdrawn
PhenobarbitalThe metabolism of Benzyl alcohol can be increased when combined with Phenobarbital.Approved, Investigational
PhenoperidineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phenoperidine.Experimental
PhenothiazineThe serum concentration of Phenothiazine can be increased when it is combined with Benzyl alcohol.Vet Approved
PhenoxypropazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phenoxypropazine.Withdrawn
PhenprobamateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phenprobamate.Experimental
PhensuximideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phensuximide.Approved
PhentermineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Phentermine.Approved, Illicit
PhenytoinThe metabolism of Benzyl alcohol can be increased when combined with Phenytoin.Approved, Vet Approved
PibrentasvirThe serum concentration of Pibrentasvir can be increased when it is combined with Benzyl alcohol.Approved, Investigational
PiclozotanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Piclozotan.Investigational
PimavanserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pimavanserin.Approved, Investigational
PimozideThe risk or severity of adverse effects can be increased when Pimozide is combined with Benzyl alcohol.Approved
PinazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pinazepam.Experimental
PindololThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pindolol.Approved, Investigational
PipamperoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pipamperone.Approved, Investigational
PipecuroniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pipecuronium.Approved
PipotiazineThe risk or severity of adverse effects can be increased when Pipotiazine is combined with Benzyl alcohol.Approved, Investigational
PiritramideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Piritramide.Approved, Investigational
PirlimycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pirlimycin.Vet Approved
PirlindoleThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pirlindole.Approved
PitavastatinThe serum concentration of Pitavastatin can be increased when it is combined with Benzyl alcohol.Approved
PitolisantThe serum concentration of Benzyl alcohol can be decreased when it is combined with Pitolisant.Approved, Investigational
PivagabineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pivagabine.Investigational
PivhydrazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pivhydrazine.Withdrawn
PizotifenThe risk or severity of adverse effects can be increased when Pizotifen is combined with Benzyl alcohol.Approved
PlazomicinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Plazomicin.Approved, Investigational
Polymyxin B SulfateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Polymyxin B Sulfate.Approved, Vet Approved
PomalidomideThe risk or severity of adverse effects can be increased when Pomalidomide is combined with Benzyl alcohol.Approved
PonatinibThe serum concentration of Ponatinib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
PosaconazoleThe metabolism of Benzyl alcohol can be decreased when combined with Posaconazole.Approved, Investigational, Vet Approved
PramipexoleBenzyl alcohol may increase the sedative activities of Pramipexole.Approved, Investigational
PravastatinThe serum concentration of Pravastatin can be increased when it is combined with Benzyl alcohol.Approved
PrazepamThe risk or severity of adverse effects can be increased when Prazepam is combined with Benzyl alcohol.Approved, Illicit
PrazosinThe serum concentration of Prazosin can be increased when it is combined with Benzyl alcohol.Approved
PrednisoloneThe serum concentration of Prednisolone can be increased when it is combined with Benzyl alcohol.Approved, Vet Approved
PrednisoneThe serum concentration of Prednisone can be increased when it is combined with Benzyl alcohol.Approved, Vet Approved
PregabalinThe therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Pregabalin.Approved, Illicit, Investigational
PridinolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pridinol.Experimental
PrimidoneThe metabolism of Benzyl alcohol can be increased when combined with Primidone.Approved, Vet Approved
ProcainamideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Procainamide.Approved
ProcaineThe risk or severity of adverse effects can be increased when Procaine is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
ProcarbazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Procarbazine.Approved, Investigational
ProchlorperazineThe risk or severity of adverse effects can be increased when Prochlorperazine is combined with Benzyl alcohol.Approved, Vet Approved
ProgabideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Progabide.Approved, Investigational
PromazineThe risk or severity of adverse effects can be increased when Promazine is combined with Benzyl alcohol.Approved, Vet Approved
PromethazineThe risk or severity of adverse effects can be increased when Promethazine is combined with Benzyl alcohol.Approved, Investigational
PropanididThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Propanidid.Experimental
PropericiazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Propericiazine.Approved, Investigational
PropiomazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Propiomazine.Approved
PropiopromazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Propiopromazine.Vet Approved
PropofolThe risk or severity of adverse effects can be increased when Propofol is combined with Benzyl alcohol.Approved, Investigational, Vet Approved
PropranololThe serum concentration of Propranolol can be increased when it is combined with Benzyl alcohol.Approved, Investigational
ProthipendylThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Prothipendyl.Investigational
ProtriptylineThe risk or severity of adverse effects can be increased when Protriptyline is combined with Benzyl alcohol.Approved
ProxibarbalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Proxibarbal.Experimental
PrucaloprideThe serum concentration of Prucalopride can be increased when it is combined with Benzyl alcohol.Approved
PRX-08066The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with PRX-08066.Investigational
PsilocybineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Psilocybine.Investigational
PuromycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Puromycin.Experimental
PyrantelThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pyrantel.Approved, Vet Approved
PyrithyldioneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pyrithyldione.Experimental
QuazepamThe risk or severity of adverse effects can be increased when Quazepam is combined with Benzyl alcohol.Approved, Illicit
QuetiapineThe risk or severity of adverse effects can be increased when Quetiapine is combined with Benzyl alcohol.Approved
QuinidineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Quinidine.Approved, Investigational
QuinineThe metabolism of Benzyl alcohol can be increased when combined with Quinine.Approved
QuinupramineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Quinupramine.Experimental
RacloprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Raclopride.Investigational
RamelteonThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ramelteon.Approved, Investigational
RamosetronThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ramosetron.Approved, Investigational
RanitidineThe serum concentration of Ranitidine can be increased when it is combined with Benzyl alcohol.Approved
RanolazineThe serum concentration of Ranolazine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
RapacuroniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Rapacuronium.Withdrawn
RasagilineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Rasagiline.Approved
ReboxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Reboxetine.Approved, Investigational
RegorafenibThe serum concentration of Regorafenib can be increased when it is combined with Benzyl alcohol.Approved
RemacemideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Remacemide.Investigational
RemifentanilThe risk or severity of adverse effects can be increased when Remifentanil is combined with Benzyl alcohol.Approved
RemoxiprideThe risk or severity of adverse effects can be increased when Remoxipride is combined with Benzyl alcohol.Approved, Withdrawn
RenzaprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Renzapride.Investigational
RepinotanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Repinotan.Investigational
ReposalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Reposal.Approved
ReserpineThe risk or severity of adverse effects can be increased when Reserpine is combined with Benzyl alcohol.Approved, Investigational
Rhodamine 6GThe serum concentration of Rhodamine 6G can be increased when it is combined with Benzyl alcohol.Experimental
RibostamycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ribostamycin.Approved, Investigational
RifampicinThe metabolism of Benzyl alcohol can be increased when combined with Rifampicin.Approved
RifamycinThe metabolism of Benzyl alcohol can be increased when combined with Rifamycin.Investigational
RifapentineThe metabolism of Benzyl alcohol can be increased when combined with Rifapentine.Approved, Investigational
RifaximinThe serum concentration of Rifaximin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
RiluzoleThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Riluzole.Approved, Investigational
RimexoloneThe metabolism of Benzyl alcohol can be increased when combined with Rimexolone.Approved
RisperidoneThe risk or severity of adverse effects can be increased when Risperidone is combined with Benzyl alcohol.Approved, Investigational
RitanserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ritanserin.Investigational
RitonavirThe metabolism of Benzyl alcohol can be decreased when combined with Ritonavir.Approved, Investigational
RivaroxabanThe serum concentration of Rivaroxaban can be increased when it is combined with Benzyl alcohol.Approved
RizatriptanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Rizatriptan.Approved
RocuroniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Rocuronium.Approved
RolipramThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Rolipram.Investigational
RolitetracyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Rolitetracycline.Approved
RomidepsinThe serum concentration of Romidepsin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
RomifidineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Romifidine.Vet Approved
RopiniroleBenzyl alcohol may increase the sedative activities of Ropinirole.Approved, Investigational
RotigotineBenzyl alcohol may increase the sedative activities of Rotigotine.Approved
RP-5063The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with RP-5063.Investigational
RucaparibThe serum concentration of Rucaparib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
RufinamideThe risk or severity of adverse effects can be increased when Rufinamide is combined with Benzyl alcohol.Approved
SafinamideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Safinamide.Approved, Investigational
SafrazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Safrazine.Withdrawn
SaquinavirThe metabolism of Benzyl alcohol can be decreased when combined with Saquinavir.Approved, Investigational
SaredutantThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Saredutant.Investigational
SarilumabThe therapeutic efficacy of Benzyl alcohol can be decreased when used in combination with Sarilumab.Approved, Investigational
SarpogrelateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Sarpogrelate.Investigational
ScopolamineThe risk or severity of adverse effects can be increased when Scopolamine is combined with Benzyl alcohol.Approved, Investigational
SecobarbitalThe risk or severity of adverse effects can be increased when Secobarbital is combined with Benzyl alcohol.Approved, Vet Approved
SelegilineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Selegiline.Approved, Investigational, Vet Approved
SelexipagThe serum concentration of Selexipag can be increased when it is combined with Benzyl alcohol.Approved
SerotoninThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Serotonin.Investigational, Nutraceutical
SertindoleThe risk or severity of adverse effects can be increased when Sertindole is combined with Benzyl alcohol.Approved, Investigational, Withdrawn
SertralineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Sertraline.Approved
SevofluraneThe risk or severity of adverse effects can be increased when Sevoflurane is combined with Benzyl alcohol.Approved, Vet Approved
SibutramineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Sibutramine.Approved, Illicit, Investigational, Withdrawn
SilodosinThe serum concentration of Silodosin can be increased when it is combined with Benzyl alcohol.Approved
SiltuximabThe serum concentration of Benzyl alcohol can be decreased when it is combined with Siltuximab.Approved, Investigational
SimeprevirThe serum concentration of Benzyl alcohol can be increased when it is combined with Simeprevir.Approved
SimvastatinThe serum concentration of Simvastatin can be increased when it is combined with Benzyl alcohol.Approved
SirolimusThe serum concentration of Sirolimus can be increased when it is combined with Benzyl alcohol.Approved, Investigational
SisomicinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Sisomicin.Investigational
SitagliptinThe serum concentration of Sitagliptin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
Sodium oxybateSodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved
SofosbuvirThe serum concentration of Sofosbuvir can be increased when it is combined with Benzyl alcohol.Approved
SomatostatinThe serum concentration of Somatostatin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
SorafenibThe serum concentration of Sorafenib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
SparfloxacinThe serum concentration of Sparfloxacin can be increased when it is combined with Benzyl alcohol.Approved, Investigational
SphingosineThe serum concentration of Sphingosine can be increased when it is combined with Benzyl alcohol.Experimental
St. John's WortThe serum concentration of Benzyl alcohol can be decreased when it is combined with St. John's Wort.Approved, Investigational, Nutraceutical
StanoloneThe serum concentration of Stanolone can be increased when it is combined with Benzyl alcohol.Illicit, Investigational
Stanolone acetateThe serum concentration of Stanolone acetate can be increased when it is combined with Benzyl alcohol.Experimental
StiripentolThe serum concentration of Benzyl alcohol can be increased when it is combined with Stiripentol.Approved
StreptomycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Streptomycin.Approved, Vet Approved
StyramateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Styramate.Experimental
SuccinylcholineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Succinylcholine.Approved
SufentanilThe risk or severity of adverse effects can be increased when Sufentanil is combined with Benzyl alcohol.Approved, Investigational
SulpirideThe risk or severity of adverse effects can be increased when Sulpiride is combined with Benzyl alcohol.Approved, Investigational
SulthiameThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Sulthiame.Experimental
SultoprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Sultopride.Experimental
SumatriptanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Sumatriptan.Approved, Investigational
SunitinibThe serum concentration of Sunitinib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
SuvorexantBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.Approved, Investigational
TacrineThe serum concentration of Tacrine can be increased when it is combined with Benzyl alcohol.Investigational, Withdrawn
TacrolimusThe serum concentration of Tacrolimus can be increased when it is combined with Benzyl alcohol.Approved, Investigational
TalbutalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Talbutal.Approved, Illicit
TalinololThe serum concentration of Talinolol can be increased when it is combined with Benzyl alcohol.Investigational
TalopramThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Talopram.Experimental
TamoxifenThe serum concentration of Tamoxifen can be increased when it is combined with Benzyl alcohol.Approved
TandospironeThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tandospirone.Investigational
TapentadolTapentadol may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.Approved
TasimelteonThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tasimelteon.Approved, Investigational
Taurocholic AcidThe serum concentration of Taurocholic Acid can be increased when it is combined with Benzyl alcohol.Experimental
TD-8954The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with TD-8954.Investigational
Technetium Tc-99m sestamibiThe serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Benzyl alcohol.Approved, Investigational
Technetium Tc-99m tilmanoceptBenzyl alcohol may decrease effectiveness of Technetium Tc-99m tilmanocept as a diagnostic agent.Approved, Investigational
Tedizolid phosphateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tedizolid phosphate.Approved
TegaserodThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tegaserod.Approved, Investigational, Withdrawn
TelaprevirThe metabolism of Benzyl alcohol can be decreased when combined with Telaprevir.Approved, Withdrawn
TelithromycinThe metabolism of Benzyl alcohol can be decreased when combined with Telithromycin.Approved
TemazepamThe risk or severity of adverse effects can be increased when Temazepam is combined with Benzyl alcohol.Approved, Investigational
TemsirolimusThe serum concentration of Temsirolimus can be increased when it is combined with Benzyl alcohol.Approved
TeniposideThe serum concentration of Teniposide can be increased when it is combined with Benzyl alcohol.Approved
TerfenadineThe serum concentration of Terfenadine can be increased when it is combined with Benzyl alcohol.Approved, Withdrawn
Testosterone propionateThe serum concentration of Testosterone propionate can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Vet Approved, Withdrawn
TetracyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tetracycline.Approved, Vet Approved
TetrahydrocannabivarinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tetrahydrocannabivarin.Investigational
TetrahydropalmatineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tetrahydropalmatine.Investigational
TetrazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tetrazepam.Experimental
TetrodotoxinThe risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Benzyl alcohol.Investigational
ThalidomideBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.Approved, Investigational, Withdrawn
ThiamylalThe risk or severity of adverse effects can be increased when Thiamylal is combined with Benzyl alcohol.Approved, Vet Approved
ThiazinamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Thiazinam.Experimental
ThiethylperazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Thiethylperazine.Withdrawn
ThiocolchicosideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Thiocolchicoside.Approved, Investigational
ThiopentalThe risk or severity of adverse effects can be increased when Thiopental is combined with Benzyl alcohol.Approved, Vet Approved
ThiopropazateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Thiopropazate.Experimental
ThioproperazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Thioproperazine.Approved
ThioridazineThe risk or severity of adverse effects can be increased when Thioridazine is combined with Benzyl alcohol.Approved, Withdrawn
ThiothixeneThe risk or severity of adverse effects can be increased when Thiothixene is combined with Benzyl alcohol.Approved
TiagabineThe risk or severity of adverse effects can be increased when Tiagabine is combined with Benzyl alcohol.Approved, Investigational
TianeptineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tianeptine.Approved, Investigational
TiaprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tiapride.Approved, Investigational
TicagrelorThe serum concentration of Ticagrelor can be increased when it is combined with Benzyl alcohol.Approved
TigecyclineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tigecycline.Approved
TiletamineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tiletamine.Vet Approved
TilidineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tilidine.Experimental
TimololThe serum concentration of Timolol can be increased when it is combined with Benzyl alcohol.Approved
TipranavirThe metabolism of Benzyl alcohol can be decreased when combined with Tipranavir.Approved, Investigational
TizanidineThe risk or severity of adverse effects can be increased when Tizanidine is combined with Benzyl alcohol.Approved, Investigational
TobramycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tobramycin.Approved, Investigational
TocilizumabThe serum concentration of Benzyl alcohol can be decreased when it is combined with Tocilizumab.Approved
TofisopamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tofisopam.Approved
TolcaponeThe risk or severity of adverse effects can be increased when Tolcapone is combined with Benzyl alcohol.Approved, Withdrawn
ToloxatoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Toloxatone.Approved
TolperisoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tolperisone.Approved, Investigational
TolvaptanThe serum concentration of Tolvaptan can be increased when it is combined with Benzyl alcohol.Approved
TopiramateThe risk or severity of adverse effects can be increased when Topiramate is combined with Benzyl alcohol.Approved
TopotecanThe serum concentration of Topotecan can be increased when it is combined with Benzyl alcohol.Approved, Investigational
TramadolThe risk or severity of adverse effects can be increased when Tramadol is combined with Benzyl alcohol.Approved, Investigational
TramiprosateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tramiprosate.Investigational
TranylcypromineThe risk or severity of adverse effects can be increased when Tranylcypromine is combined with Benzyl alcohol.Approved, Investigational
Trastuzumab emtansineThe serum concentration of Trastuzumab emtansine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
TrazodoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Trazodone.Approved, Investigational
TriazolamThe risk or severity of adverse effects can be increased when Triazolam is combined with Benzyl alcohol.Approved, Investigational
Tricaine methanesulfonateThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tricaine methanesulfonate.Vet Approved
TrichloroethyleneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Trichloroethylene.Approved
TriclofosThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Triclofos.Withdrawn
TrifluoperazineThe risk or severity of adverse effects can be increased when Trifluoperazine is combined with Benzyl alcohol.Approved, Investigational
TrifluperidolThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Trifluperidol.Experimental
TriflupromazineThe risk or severity of adverse effects can be increased when Triflupromazine is combined with Benzyl alcohol.Approved, Vet Approved
TrimethadioneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Trimethadione.Approved
TrimipramineThe risk or severity of adverse effects can be increased when Trimipramine is combined with Benzyl alcohol.Approved
TriprolidineThe risk or severity of adverse effects can be increased when Triprolidine is combined with Benzyl alcohol.Approved
TroleandomycinThe metabolism of Benzyl alcohol can be decreased when combined with Troleandomycin.Approved
TropisetronThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tropisetron.Approved, Investigational
TubocurarineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Tubocurarine.Approved
UbidecarenoneThe serum concentration of Ubidecarenone can be increased when it is combined with Benzyl alcohol.Approved, Investigational, Nutraceutical
UmeclidiniumThe serum concentration of Umeclidinium can be increased when it is combined with Benzyl alcohol.Approved
UrapidilThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Urapidil.Investigational
VabicaserinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vabicaserin.Investigational
ValerianThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Valerian.Approved, Experimental, Investigational
ValinomycinThe serum concentration of Valinomycin can be increased when it is combined with Benzyl alcohol.Experimental
ValnoctamideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Valnoctamide.Investigational
Valproic AcidThe risk or severity of adverse effects can be increased when Valproic Acid is combined with Benzyl alcohol.Approved, Investigational
ValpromideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Valpromide.Experimental
ValspodarThe serum concentration of Valspodar can be increased when it is combined with Benzyl alcohol.Investigational
VancomycinThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vancomycin.Approved
VecuroniumThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vecuronium.Approved
VelpatasvirThe serum concentration of Velpatasvir can be increased when it is combined with Benzyl alcohol.Approved, Investigational
VemurafenibThe serum concentration of Benzyl alcohol can be decreased when it is combined with Vemurafenib.Approved
VenetoclaxThe serum concentration of Venetoclax can be increased when it is combined with Benzyl alcohol.Approved, Investigational
VenlafaxineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Venlafaxine.Approved
VeraliprideThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Veralipride.Experimental
VerapamilThe serum concentration of Verapamil can be increased when it is combined with Benzyl alcohol.Approved
VigabatrinThe risk or severity of adverse effects can be increased when Vigabatrin is combined with Benzyl alcohol.Approved
VilazodoneThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vilazodone.Approved
ViloxazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Viloxazine.Approved, Investigational, Withdrawn
VinbarbitalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vinbarbital.Experimental
VinblastineThe serum concentration of Vinblastine can be increased when it is combined with Benzyl alcohol.Approved
VincristineThe excretion of Vincristine can be decreased when combined with Benzyl alcohol.Approved, Investigational
VinflunineThe serum concentration of Vinflunine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
VinorelbineThe serum concentration of Vinorelbine can be increased when it is combined with Benzyl alcohol.Approved, Investigational
VinpocetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vinpocetine.Investigational
Vinyl etherThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vinyl ether.Experimental
VinylbitalThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vinylbital.Experimental
VismodegibThe serum concentration of Vismodegib can be increased when it is combined with Benzyl alcohol.Approved, Investigational
VoriconazoleThe metabolism of Benzyl alcohol can be decreased when combined with Voriconazole.Approved, Investigational
VortioxetineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vortioxetine.Approved, Investigational
VoxilaprevirThe serum concentration of Voxilaprevir can be increased when it is combined with Benzyl alcohol.Approved, Investigational
WortmanninThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Wortmannin.Experimental
XP19986The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with XP19986.Investigational
XylazineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Xylazine.Vet Approved
YKP-1358The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with YKP-1358.Investigational
YohimbineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Yohimbine.Approved, Investigational, Vet Approved
ZaleplonThe risk or severity of adverse effects can be increased when Zaleplon is combined with Benzyl alcohol.Approved, Illicit, Investigational
ZiconotideThe risk or severity of adverse effects can be increased when Ziconotide is combined with Benzyl alcohol.Approved
ZidovudineThe serum concentration of Zidovudine can be increased when it is combined with Benzyl alcohol.Approved
ZimelidineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zimelidine.Withdrawn
ZiprasidoneThe risk or severity of adverse effects can be increased when Ziprasidone is combined with Benzyl alcohol.Approved
ZolazepamThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zolazepam.Vet Approved
ZolmitriptanThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zolmitriptan.Approved, Investigational
ZolpidemBenzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.Approved
ZonisamideThe risk or severity of adverse effects can be increased when Zonisamide is combined with Benzyl alcohol.Approved, Investigational
ZopicloneThe risk or severity of adverse effects can be increased when Zopiclone is combined with Benzyl alcohol.Approved
ZotepineThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zotepine.Approved, Investigational, Withdrawn
ZuclopenthixolThe risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Benzyl alcohol.Approved, Investigational
Food Interactions
Not Available

References

Synthesis Reference

Cornelis Jongsma, Leon H. B. Frijns, Paula A. M. Raven-Donners, "Method for the preparation of a pure alkali metal benzoate and benzyl alcohol." U.S. Patent US4296245, issued June, 1940.

US4296245
General References
  1. Taylor PM, Chengelis CP, Miller WR, Parker GA, Gleason TR, Cozzi E: Evaluation of propofol containing 2% benzyl alcohol preservative in cats. J Feline Med Surg. 2012 Aug;14(8):516-26. doi: 10.1177/1098612X12440354. Epub 2012 Feb 24. [PubMed:22366290]
  2. Novak E, Stubbs SS, Sanborn EC, Eustice RM: The tolerance and safety of intravenously administered benzyl alcohol in methylprednisolone sodium succinate formulations in normal human subjects. Toxicol Appl Pharmacol. 1972 Sep;23(1):54-61. [PubMed:4560999]
  3. Meinking TL, Villar ME, Vicaria M, Eyerdam DH, Paquet D, Mertz-Rivera K, Rivera HF, Hiriart J, Reyna S: The clinical trials supporting benzyl alcohol lotion 5% (Ulesfia): a safe and effective topical treatment for head lice (pediculosis humanus capitis). Pediatr Dermatol. 2010 Jan-Feb;27(1):19-24. doi: 10.1111/j.1525-1470.2009.01059.x. [PubMed:20199404]
External Links
Human Metabolome Database
HMDB0003119
KEGG Drug
D00077
KEGG Compound
C03485
PubChem Compound
244
PubChem Substance
175427090
ChemSpider
13860335
ChEBI
17987
ChEMBL
CHEMBL720
PharmGKB
PA448594
HET
010
RxList
RxList Drug Page
Wikipedia
Benzyl_alcohol
ATC Codes
P03AX06 — Benzyl alcohol
PDB Entries
2amq / 2hob / 2q6f / 3d23 / 3iwm / 4ii8 / 5eb5 / 5eu8 / 5gwy / 5gwz
FDA label
Download (1.05 MB)
MSDS
Download (50.6 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedTreatmentOtitis Externa1
3CompletedTreatmentLice of the head1
4CompletedTreatmentHip Pain1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
CreamTopical10 mg/g
GelTopical2.5 %
LotionDental25 mg
GelDental25 mg
SuspensionAuricular (otic)
GelBuccal; Topical
OintmentTopical
GelTopical
CreamTopical
SprayTopical
Aerosol, sprayTopical
GelTopical100 mg/g
CreamPercutaneous; Topical; Transdermal
LiquidPercutaneous; Topical; Transdermal
LiquidTopical
LotionTopical50 mg/g
GelTopical.1 g/g
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)
US5858383No1997-08-112017-08-11Us
US6139859No1997-08-112017-08-11Us
US6793931No2002-07-112022-07-11Us
US7294342No2004-05-192024-05-19Us

Properties

State
Liquid
Experimental Properties
PropertyValueSource
melting point (°C)-15..2 °C, 258 K, 5 °F# http://sitem.herts.ac.uk/aeru/footprint/en/Reports/953.htm.
boiling point (°C)205.3 °C, 478 K, 402 °F# http://sitem.herts.ac.uk/aeru/footprint/en/Reports/953.htm.
water solubility33 mg/mL, clear, colorless# http://www.chemicalbook.com/ProductChemicalPropertiesCB3852587_EN.htm
logP1.1# http://sitem.herts.ac.uk/aeru/footprint/en/Reports/953.htm.
pKa15.4# http://sitem.herts.ac.uk/aeru/footprint/en/Reports/953.htm.
Predicted Properties
PropertyValueSource
Water Solubility26.8 mg/mLALOGPS
logP1.07ALOGPS
logP1.21ChemAxon
logS-0.61ALOGPS
pKa (Strongest Acidic)15.02ChemAxon
pKa (Strongest Basic)-2.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area20.23 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity32.87 m3·mol-1ChemAxon
Polarizability11.89 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.9906
Blood Brain Barrier+0.9698
Caco-2 permeable+0.8859
P-glycoprotein substrateNon-substrate0.8373
P-glycoprotein inhibitor INon-inhibitor0.9803
P-glycoprotein inhibitor IINon-inhibitor0.9629
Renal organic cation transporterNon-inhibitor0.8259
CYP450 2C9 substrateNon-substrate0.7995
CYP450 2D6 substrateNon-substrate0.9234
CYP450 3A4 substrateNon-substrate0.8408
CYP450 1A2 substrateInhibitor0.5434
CYP450 2C9 inhibitorNon-inhibitor0.9285
CYP450 2D6 inhibitorNon-inhibitor0.9623
CYP450 2C19 inhibitorNon-inhibitor0.7859
CYP450 3A4 inhibitorNon-inhibitor0.9558
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8458
Ames testNon AMES toxic0.9645
CarcinogenicityNon-carcinogens0.5381
BiodegradationReady biodegradable0.8774
Rat acute toxicity1.9753 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8998
hERG inhibition (predictor II)Non-inhibitor0.9625
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Download (7.19 KB)
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (1 TMS)GC-MSsplash10-00ko-6900000000-a9d668ecd37a1579a6fe
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - EI-BGC-MSsplash10-056r-9400000000-77cec715500da9c57a84
GC-MS Spectrum - EI-BGC-MSsplash10-056r-9400000000-8dc38068387df3fa06aa
GC-MS Spectrum - EI-BGC-MSsplash10-056r-9300000000-fb124b56257906cce9f1
GC-MS Spectrum - EI-BGC-MSsplash10-056r-9400000000-7a77e67486ae3b2dd855
GC-MS Spectrum - EI-BGC-MSsplash10-056r-9400000000-dd0878988e7c2d9a5431
GC-MS Spectrum - GC-MSGC-MSsplash10-00ko-6900000000-a9d668ecd37a1579a6fe
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0006-8900000000-c256b0b7a0755f08ac64
Mass Spectrum (Electron Ionization)MSsplash10-056r-9400000000-a8f1fd78fa3f8781f296
MS/MS Spectrum - Quattro_QQQ 10V, N/A (Annotated)LC-MS/MSsplash10-0a4i-9500000000-2a82c3dd7c6871f61c34
MS/MS Spectrum - Quattro_QQQ 25V, N/A (Annotated)LC-MS/MSsplash10-0006-9000000000-ad1762d5292c30b29bbd
MS/MS Spectrum - Quattro_QQQ 40V, N/ALC-MS/MSsplash10-0006-9000000000-3c8d4c630cf42e3bfd3f
MS/MS Spectrum - EI-B (HITACHI RMU-7M) , PositiveLC-MS/MSsplash10-056r-9400000000-c4dcb2148958f946cd01
MS/MS Spectrum - EI-B (HITACHI RMU-6M) , PositiveLC-MS/MSsplash10-056r-9400000000-e17e577dbe4546313a91
MS/MS Spectrum - EI-B (JEOL JMS-01-SG-2) , PositiveLC-MS/MSsplash10-056r-9300000000-fb124b56257906cce9f1
MS/MS Spectrum - EI-B (HITACHI M-80) , PositiveLC-MS/MSsplash10-056r-9400000000-47b3605316c57e02b84f
MS/MS Spectrum - EI-B (HITACHI M-80B) , PositiveLC-MS/MSsplash10-056r-9400000000-dd0878988e7c2d9a5431
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-0900000000-3a71c23796a048eb999c
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-1900000000-40737e7bdf548d714249
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0uxr-9100000000-23e82914cfa9372ecafc
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-1900000000-17f95f5a398b5850abb2
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a6r-7900000000-733d283e0916e755a736
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9000000000-d0c6e5fc39516ee594b4
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0a4i-3900000000-4d1bf15f6cf8f65bf0a6
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable

Taxonomy

Description
This compound belongs to the class of organic compounds known as benzyl alcohols. These are organic compounds containing the phenylmethanol substructure.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzyl alcohols
Direct Parent
Benzyl alcohols
Alternative Parents
Primary alcohols / Hydrocarbon derivatives / Aromatic alcohols
Substituents
Benzyl alcohol / Organic oxygen compound / Hydrocarbon derivative / Aromatic alcohol / Primary alcohol / Organooxygen compound / Alcohol / Aromatic homomonocyclic compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
benzyl alcohols (CHEBI:17987) / an aromatic compound (BENZYL-ALCOHOL)

Enzymes

Kind
Protein
Organism
Human
Pharmacological action
Unknown
Actions
Substrate
General Function
Steroid hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP2C8
Uniprot ID
P10632
Uniprot Name
Cytochrome P450 2C8
Molecular Weight
55824.275 Da
References
  1. Nakajima T, Wang RS, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H, Aoyama T: Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. Biochem Pharmacol. 1997 Feb 7;53(3):271-7. [PubMed:9065730]
  2. Kim H, Wang RS, Elovaara E, Raunio H, Pelkonen O, Aoyama T, Vainio H, Nakajima T: Cytochrome P450 isozymes responsible for the metabolism of toluene and styrene in human liver microsomes. Xenobiotica. 1997 Jul;27(7):657-65. [PubMed:9253143]
Kind
Protein
Organism
Human
Pharmacological action
Unknown
General Function
Vitamin d 24-hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP1A1
Uniprot ID
P04798
Uniprot Name
Cytochrome P450 1A1
Molecular Weight
58164.815 Da
References
  1. Furman GM, Silverman DM, Schatz RA: Inhibition of rat lung mixed-function oxidase activity following repeated low-level toluene inhalation: possible role of toluene metabolites. J Toxicol Environ Health A. 1998 Aug 21;54(8):633-45. [PubMed:9726784]
  2. Nakajima T, Wang RS, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H, Aoyama T: Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. Biochem Pharmacol. 1997 Feb 7;53(3):271-7. [PubMed:9065730]
Kind
Protein
Organism
Human
Pharmacological action
Unknown
Actions
Substrate
General Function
Electron carrier activity
Specific Function
Not Available
Gene Name
ALDH2
Uniprot ID
P05091
Uniprot Name
Aldehyde dehydrogenase, mitochondrial
Molecular Weight
56380.93 Da
References
  1. Kawamoto T, Koga M, Murata K, Matsuda S, Kodama Y: Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans. Toxicol Appl Pharmacol. 1995 Aug;133(2):295-304. [PubMed:7645026]
Kind
Protein
Organism
Human
Pharmacological action
Unknown
Actions
Substrate
General Function
Steroid hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP2B6
Uniprot ID
P20813
Uniprot Name
Cytochrome P450 2B6
Molecular Weight
56277.81 Da
References
  1. Nakajima T, Wang RS, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H, Aoyama T: Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. Biochem Pharmacol. 1997 Feb 7;53(3):271-7. [PubMed:9065730]
Kind
Protein
Organism
Human
Pharmacological action
Unknown
Actions
Substrate
General Function
Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP1A2
Uniprot ID
P05177
Uniprot Name
Cytochrome P450 1A2
Molecular Weight
58293.76 Da
References
  1. Nakajima T, Wang RS, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H, Aoyama T: Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. Biochem Pharmacol. 1997 Feb 7;53(3):271-7. [PubMed:9065730]
  2. Kim H, Wang RS, Elovaara E, Raunio H, Pelkonen O, Aoyama T, Vainio H, Nakajima T: Cytochrome P450 isozymes responsible for the metabolism of toluene and styrene in human liver microsomes. Xenobiotica. 1997 Jul;27(7):657-65. [PubMed:9253143]
Kind
Protein
Organism
Human
Pharmacological action
Unknown
Actions
Substrate
General Function
Steroid hydroxylase activity
Specific Function
Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic ...
Gene Name
CYP2E1
Uniprot ID
P05181
Uniprot Name
Cytochrome P450 2E1
Molecular Weight
56848.42 Da
References
  1. Nakajima T, Wang RS, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H, Aoyama T: Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. Biochem Pharmacol. 1997 Feb 7;53(3):271-7. [PubMed:9065730]
  2. Lipscomb JC, Barton HA, Tornero-Velez R, Evans MV, Alcasey S, Snawder JE, Laskey J: The metabolic rate constants and specific activity of human and rat hepatic cytochrome P-450 2E1 toward toluene and chloroform. J Toxicol Environ Health A. 2004 Apr 9;67(7):537-53. [PubMed:15129551]
  3. Kim H, Wang RS, Elovaara E, Raunio H, Pelkonen O, Aoyama T, Vainio H, Nakajima T: Cytochrome P450 isozymes responsible for the metabolism of toluene and styrene in human liver microsomes. Xenobiotica. 1997 Jul;27(7):657-65. [PubMed:9253143]
  4. Wang RS, Nakajima T, Park SS, Gelboin HV, Murayama N: Monoclonal antibody-directed assessment of toluene induction of rat hepatic cytochrome P450 isozymes. Biochem Pharmacol. 1993 Aug 3;46(3):413-9. [PubMed:8347164]
Kind
Protein
Organism
Human
Pharmacological action
Unknown
Actions
Substrate
General Function
Steroid hydroxylase activity
Specific Function
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic...
Gene Name
CYP2D6
Uniprot ID
P10635
Uniprot Name
Cytochrome P450 2D6
Molecular Weight
55768.94 Da
References
  1. Obach RS: Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs. Drug Metab Dispos. 2001 Dec;29(12):1599-607. [PubMed:11717179]
Kind
Protein
Organism
Human
Pharmacological action
Unknown
Actions
Substrate
General Function
Vitamin d3 25-hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation react...
Gene Name
CYP3A4
Uniprot ID
P08684
Uniprot Name
Cytochrome P450 3A4
Molecular Weight
57342.67 Da
References
  1. Obach RS: Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs. Drug Metab Dispos. 2001 Dec;29(12):1599-607. [PubMed:11717179]

Drug created on September 14, 2010 10:21 / Updated on August 02, 2018 05:39